window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : February 16, 2026

  • News
  • About Us
Contact Us

UK cancer treatment

  • Clinical Trials,Drug Development,Oncology,Regulatory Affairs

    UK approves cabozantinib Ipsen for previously treated advanced neuroendocrine tumours

    The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has [...]

    September 27, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • IgniteData appoints Laura Hilty as CSO and Joe Lengfellner as CPO amid Series A funding close
    Categories: Clinical Development, Data Management, Digital Health, Movers & Shakers, Technology and platforms
  • Hans Schambye appointed as CEO of BOOST Pharma as BT‑101 advances toward Phase 3
    Categories: Biotech, Cell & Gene Therapy, Clinical Development, Movers & Shakers, Pharmaceuticals and therapeutics, Rare Diseases
  • SPT Labtech and BellBrook Labs unveil high-throughput screening platform targeting VPS4B in cancer research
    Categories: Biotech, Drug Development, Oncology, Research & Development, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top